We are live on ! Find out more
HCWB icon

HCW Biologics
HCWB

14 hedge funds and large institutions have $326K invested in HCW Biologics in 2025 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

0.02% less ownership

Funds ownership: 0.03% → 0.01% (-0.02%)

22% less funds holding

Funds holding: 18 → 14 (-4)

50% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 8

77% less capital invested

Capital invested by funds: $1.4M → $326K (-$1.07M)

Holders
14
Holders Change
-4
Holders Change %
-22.22%
% of All Funds
0.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
2
Reduced
1
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$75.2K
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$20.1K
3
JWCA
J.W. Cole Advisors
Florida
+$19.6K
4
VPIM
Vanguard Personalized Indexing Management
California
+$5.98K
5
Citigroup
Citigroup
New York
+$5.19K

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$903K
2
HighTower Advisors
HighTower Advisors
Illinois
-$80.7K
3
BCM
Bridgeway Capital Management
Texas
-$15.5K
4
XT
XTX Topco
Cayman Islands
-$15.2K
5
VF
Virtu Financial
New York
-$7K
Name Holding Trade Value Shares
Change 		Change in
Stake
APP
1
Avantax Planning Partners
Iowa
$78.9K – – –
Vanguard Group
2
Vanguard Group
Pennsylvania
$68.6K +$75.2K +856 +545%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$66.9K +$20.1K +229 +30%
CAM
4
Cresset Asset Management
Illinois
$37.2K – – –
PIM
5
Pullen Investment Management
Florida
$21.2K – – –
JWCA
6
J.W. Cole Advisors
Florida
$15.1K +$19.6K +223 New
BlackRock
7
BlackRock
New York
$11.9K -$264 -3 -2%
AWM
8
AE Wealth Management
Kansas
$8.46K – – –
State Street
9
State Street
Massachusetts
$6.05K – – –
VPIM
10
Vanguard Personalized Indexing Management
California
$4.59K +$5.98K +68 New
Citigroup
11
Citigroup
New York
$3.96K +$5.19K +59 New
Northern Trust
12
Northern Trust
Illinois
$2.88K – – –
Osaic Holdings
13
Osaic Holdings
Arizona
$285 +$352 +4 New
Bank of America
14
Bank of America
North Carolina
$59 – – –
TRCT
15
Tower Research Capital (TRC)
New York
$9 -$615 -7 Closed
AC
16
Armistice Capital
New York
– -$903K -8,432 Closed
HighTower Advisors
17
HighTower Advisors
Illinois
– -$80.7K -753 Closed
BCM
18
Bridgeway Capital Management
Texas
– -$15.5K -145 Closed
XT
19
XTX Topco
Cayman Islands
– -$15.2K -142 Closed
VF
20
Virtu Financial
New York
– -$7K -65 Closed
Renaissance Technologies
21
Renaissance Technologies
New York
– -$6.69K -63 Closed
Two Sigma Investments
22
Two Sigma Investments
New York
– -$5.39K -50 Closed

HCWB Hedge Fund Activity: Q1 2025 in Review

14 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in HCW Biologics (HCWB) for Q1 2025, worth a combined $326K — down 77% from $1.4M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of HCWB and 4 opened new positions — a net loss of 4 holders — while 1 trimmed existing stakes and 2 added.

The largest buyer was Vanguard Group, adding an estimated $75.2K. The largest seller was Armistice Capital, exiting entirely with an estimated $903K sold.

  • 14 institutional investors held HCW Biologics (HCWB) as of Q1 2025, down from 18 in Q4 2024.
  • Funds reported $326K of HCW Biologics stock for Q1 2025, down 77% quarter-over-quarter.
  • 4 funds opened new HCW Biologics positions in Q1 2025 and 8 closed out, a net change of -4 holders.
  • The largest HCW Biologics buyer in Q1 2025 was Vanguard Group, an estimated $75.2K added.
  • The largest HCW Biologics seller in Q1 2025 was Armistice Capital, an estimated $903K sold.

Based on aggregated 13F filings for Q1 2025.